GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)
India
· Delayed Price · Currency is INR
2,136.20
+73.90 (3.58%)
At close: Jan 20, 2025
GlaxoSmithKline Pharmaceuticals Revenue
GlaxoSmithKline Pharmaceuticals had revenue of 10.11B INR in the quarter ending September 30, 2024, with 5.62% growth. This brings the company's revenue in the last twelve months to 35.60B, up 7.62% year-over-year. In the fiscal year ending March 31, 2024, GlaxoSmithKline Pharmaceuticals had annual revenue of 34.54B with 6.21% growth.
Revenue (ttm)
35.60B
Revenue Growth
+7.62%
P/S Ratio
10.19
Revenue / Employee
11.09M
Employees
3,211
Market Cap
362.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 34.54B | 2.02B | 6.21% |
Mar 31, 2023 | 32.52B | -263.06M | -0.80% |
Mar 31, 2022 | 32.78B | 3.52B | 12.05% |
Mar 31, 2021 | 29.26B | -2.99B | -9.27% |
Mar 31, 2020 | 32.24B | 962.62M | 3.08% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
Hindustan Unilever | 624.10B |
GlaxoSmithKline Pharmaceuticals News
- 2 months ago - GSK Pharma sets record date for Rs 12 special interim dividend on November 7, 2024 - Business Upturn